Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative ferric carboxymaltose for non-anaemic surgical patients with low iron stores
ACTRN12620000314921Phase 4Not yet recruiting
- Sponsor
- The University of Western Australia
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Ferinject with Placebo (2 arms). Primary endpoints: Feasibility of research protocol - recruitment rate and Feasibility of research protocol - patient acceptability. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12620000314921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000314921.